cancer patients
type of cancer medicine
Current cancer treatment
Precision Cancer Medicine Pipeline
benefits of personalized cancer medicine
field of personalized cancer medicine
average cancer patient
treatment market
personalized treatment
health services
PubGene
major market opportunity
market drivers
complete new market
clinical treatment support
complete pipeline
health providers
effects
patient outcomes
project
cost
significant business opportunity
ineffective treatments
annual increase
large-scale commercialization
expected annual turnover
non-efficacious treatments
biggest beneficiary of PCMPS
Generation Sequencing
strong positions
intolerable strain
waste time
doctors
western world
suite of applications
life expectancy
necessary steps
aging population
money
governments
tools
solutions
worldwide markets
payers
years
need
miss
approach
therapy
toll
head
beneficiaries
PMCPS
EU
Accomplishment